Table 1 Demographics and clinical and bronchoscopic characteristics of patients
From: Flexible bronchoscopy may decrease respiratory muscle strength: premedicational midazolam in focus
Variables | All patients (n = 140) | |
|---|---|---|
Age, y | 58.1 ±13.5 | |
Male gender, n (%) | 102 (72.9) | |
Patients with COPD, n (%) | 44 (31.4) | |
History of smoking, n (%) | 73 (52.1) | |
Smoking pack years | 38.4 ±22.4 | |
Duration of bronchoscopy (min) | 15.9 ±6.1 | |
Patient comfort (VAS mm) | 78.8 ±17.1 | |
Midazolam groups, n | ||
Non | 34 | |
Low-dose | 66 | |
High-dose | 40 | |
Complications, n (%) | ||
Tachycardia | 62 (44.3) | |
Bradycardia | 2 (1.4) | |
Hypotension | 1 (0.7) | |
Hypertension | 13 (9.3) | |
Desaturation | 4 (2.9) | |